stoxline Quote Chart Rank Option Currency Glossary
  
Zentek Ltd. (ZTEK)
1.2021  -0.008 (-0.65%)    03-28 16:00
Open: 1.2
High: 1.21
Volume: 10,685
  
Pre. Close: 1.21
Low: 1.17
Market Cap: 121(M)
Technical analysis
2024-03-28 4:55:23 PM
Short term     
Mid term     
Targets 6-month :  1.48 1-year :  1.56
Resists First :  1.27 Second :  1.34
Pivot price 1.27
Supports First :  1.15 Second :  0.96
MAs MA(5) :  1.23 MA(20) :  1.26
MA(100) :  1.22 MA(250) :  1.36
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  15.6 D(3) :  28.6
RSI RSI(14): 43
52-week High :  1.75 Low :  0.97
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ZTEK ] has closed above bottom band by 4.1%. Bollinger Bands are 43.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.21 - 1.22 1.22 - 1.22
Low: 1.15 - 1.16 1.16 - 1.17
Close: 1.19 - 1.2 1.2 - 1.21
Company Description

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

Headline News

Mon, 25 Mar 2024
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA - The Caledonian-Record

Mon, 11 Mar 2024
Scotia Capital Inc. Has $567000 Position in Zentek Ltd. (NASDAQ:ZTEK) - Defense World

Wed, 13 Dec 2023
Zentek Launches Triera Biosciences Ltd. - Yahoo Finance

Wed, 29 Nov 2023
Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant - Yahoo Finance

Tue, 21 Nov 2023
Zentek Announces Update on the Albany Graphite Project - Yahoo Finance

Thu, 24 Aug 2023
Zentek Announces Distribution and Supply Agreement with Henry Schein, Inc. - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 101 (M)
Held by Insiders 9.547e+007 (%)
Held by Institutions 5.9 (%)
Shares Short 95 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.223e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -23 %
Return on Assets (ttm) 68.2 %
Return on Equity (ttm) -29.2 %
Qtrly Rev. Growth 33610 %
Gross Profit (p.s.) -21.28
Sales Per Share -57.62
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow 4.69
Stock Dividends
Dividend 0
Forward Dividend 86100
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android